JNJ vs AMGN — Key Metrics

Metric JNJ (JOHNSON & JOHNSON) AMGN (AMGEN INC)
Price272.7443.89
Market Cap656.47 Billion240.11 Billion
P/E (TTM)40.8225.54
P/B (Quarterly)7.61118.033
P/S (TTM)6.616.17
Net Profit Margin (TTM)16.224.1
Gross Margin (TTM)67.670.9
ROE (TTM)19.685.6
Revenue Growth YoY (TTM)n/an/a

Upfront Investment - S&P 500 Stock Comparison & AI Analysis

AI-powered analysis and comparison tools for S&P 500 stocks, helping investors make data-driven decisions with delayed market data and portfolio modeling.

JOHNSON & JOHNSON
vs
 
AMGEN INC
 
JOHNSON & JOHNSON
vs
 
AMGEN INC
Performance Comparison
AI Model Recommendation
JNJ · JOHNSON & JOHNSON

Outperform

21
UnderperformOutperform
AMGN · AMGEN INC

Outperform

38
UnderperformOutperform
Recommendation Summary

Both stocks are projected to outperform the market over the next year. If you have to make a choice, Upfront Recommendation: AMGN.

Financial Metrics
Prices delayed ~15 min
JNJ Metrics AMGN
$272.70 Price $443.89
— Market Capitalization —
40.82 Price to Earnings Ratio 25.54
6.61 Price to Sales 6.17
31.88 Price to FCF Ratio 25.06
9.78 Price to Gross Profit 8.7
40.82 Price to R&D 30.63
11.65 Price to Current Assets 6.99

JNJ vs AMGN at a glance

Johnson & Johnson (JNJ) and Amgen INC (AMGN) are both Drug Manufacturers - General companies in the Healthcare sector. JNJ is the larger, at $656.5 billion in market value against $240.1 billion for AMGN, about 2.7 times the size.

On trailing-twelve-month figures, JNJ trades at 40.8 times trailing earnings and AMGN at 25.5; net profit margins are 16.2% and 24.1%.

The Upfront Investment model currently rates both Outperform as of November 18, 2026. The rating ranks the model's medium-term return forecast against the other stocks it scores; it is a statistical forecast, not investment advice.